Advertisement

Overview for management

  • Y. Sawamura
  • H. Shirato

Abstract

Each subcategory of GCTs is comprised of neoplasms that are relatively rare, which makes it difficult to choose an appropriate therapeutic regimen. Moreover, the similarity of the clinical presentations and radiological findings for these tumors makes selection of the management protocol even more complex. The degree to which radiation therapy should be combined with chemotherapy in the treatment of each type of GCTs, therefore, has been debatable. Recently the introduction of chemotherapy has allowed for a reduction in the conventional dose and volume of radiation used in the treatment of patients with germinoma without compromising disease control [3,6,44] (see chapter of Chemotherapy). Aggressive combination therapy may serve to improve the poor survival rates of patients with highly malignant GCTs. Neurosurgical care, as the primary mode of therapy, should be planned for each GCT while keeping in mind the known efficacy of postsurgical adjuvant therapy and the prognosis associated with its use [44].

Keywords

Embryonal Carcinoma Mature Teratoma Prognosis Group Immature Teratoma Intracranial Germ Cell Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Allen JC, Kim JH, Packer RJ (1987) Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. J Neurosurg 67: 65–70PubMedCrossRefGoogle Scholar
  2. 2.
    Allen JC (1991) Controversies in the management of intracranial germ cell tumors. Neurologic Clinics 9: 441–452PubMedGoogle Scholar
  3. 3.
    Allen JC, DaRosso RC, Donahue B, Nirenberg A (1994) A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system. Cancer 14: 940–944CrossRefGoogle Scholar
  4. 4.
    Amendola BE, McClatchey K, Amendola MA (1984) Pineal region tumors: Analysis of treatment results. Int J Radiat Oncol Biol Phys 10: 991–997PubMedCrossRefGoogle Scholar
  5. 5.
    Ball D, Barrett A, Peckman MJ (1982) The management of metastatic seminoma testis. Cancer 50: 2289–2294PubMedCrossRefGoogle Scholar
  6. 6.
    Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, Maher P, Vlamis V, Walker RW, Leibel S, Finlay JL (1996) Chemotherapy without irradiation — A novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. J Clin Oncol 14: 2908–2915PubMedGoogle Scholar
  7. 7.
    Bayens YC, Helle PA, Van Putten WL, Mali SP (1992) Orchidectomy followed by radiotherapy in 176 stage I and II testicular seminoma patients: benefits of a 10-year follow-up study. Radiother Oncol 25: 97–102PubMedCrossRefGoogle Scholar
  8. 8.
    Calaminus G, Bamberg M, Baranzelli MC, Benoit Y, di Montezemolo LC, Fossati-Bellani F, Jürgens H, Kühl HJ, Lenard HG, Curto ML (1994) Intracranial germ cell tumors: a comprehensive update of the Eurpoean data. Neuropediatrics 25: 26–32PubMedCrossRefGoogle Scholar
  9. 9.
    Calaminus G, Bamberg M, Harms D et al (1995) Intracranial germ cell tumors (GCTS): Results of the MAKEI 89 therapy protocol. Med Pediatr Oncol 23: 233 (abstract)Google Scholar
  10. 10.
    Dearnaley DP, A’Hern RP, Whittaker S, Bloom HJ (1990) Pineal and CNS germ cell tumors: Royal Marsden Hospital experience 1962–1987. Int J Radiat Oncol Biol Phys 18: 773–781PubMedCrossRefGoogle Scholar
  11. 11.
    Fields Kk, Elfenbein GJ, Lazarus HM, Cooper BW, Perkins JB, Creger RJ, Ballester OF, Hiemenz JH, Janssen WE, Zorsky PE (1995) Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: Toxicity profile. J Clin Oncol 13: 323–332PubMedGoogle Scholar
  12. 12.
    Fujimaki T, Matsutani M, Funada N, Kirino T, Takakura K, Nakamura O, Tamura A, Sano K (1994) CT and MRI features of intracranial germ cell tumors. J Neurooncol 19: 217–226PubMedCrossRefGoogle Scholar
  13. 13.
    Garre ML, El-Hossainy MO, Fondelli P, Gobel U, Brisigotti M, Donati PT, Nantron M, Ravegnani M, Garaventa A, De Bernardi B (1996) Is chemotherapy effective therapy for intracranial immature teratoma? A case report. Cancer 77: 977–982PubMedCrossRefGoogle Scholar
  14. 14.
    Ginsberg S, Kirshner J, Reich S, Panasci L, Finkelstein T, Fandlich S, Fitzpatrick A, Shechtman L, Comis R (1981) Systemic chemotherapy for a primary germ cell tumors of the brain. A pharmacokinetic study. Cancer Treat Rep 65: 477–483PubMedGoogle Scholar
  15. 15.
    Goebel U, Bamberg M, Calaminus G, Gnekow AK, Herrman HD, Lenard HG, Spaar HJ, Niethammer D, Kühl J, Harms D (1993) Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol. Klin Paediatr 205: 217–224CrossRefGoogle Scholar
  16. 16.
    Graziano SL, Paolozzi FP, Rudolph AR, Stewart WA, Elbadawi A, Comis RL (1987) Mixed germ-cell tumor of the pineal region. Case report. J Neurosurg 66: 300–304Google Scholar
  17. 17.
    Harstrick A, Schmoll HJ, Wilke H, Kohne-Wompner CH, Stahl M, Schober C, Casper J, Bruderek L, Schmoll E, Bokemeyer C (1991) Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma. J Clin Oncol 9: 1549–1555PubMedGoogle Scholar
  18. 18.
    Herrman HD, Westphal M, Winkler K, Laas RW, Schulte FJ (1994) Treatment of nongerminomatous germ-cell tumors of the pineal region. Neurosurgery 34: 524–529CrossRefGoogle Scholar
  19. 19.
    Hoffman HJ, Otsubo H, Hendrick EB, Humphrey RP, Drake JM, Becker LE, Greenberg M, Jenkin D (1991) Intracranial germ-cell tumors in children. J Neurosurg 74: 545–551PubMedCrossRefGoogle Scholar
  20. 20.
    Horowitz MB, Hall WA (1991) Central nervous system germinomas. A review. Arch Neurol 48: 652–657PubMedGoogle Scholar
  21. 21.
    Itoyama Y, Kochi M, Yamamoto H, Kuratsu J, Uemura S, Ushio Y (1990) Clinical study of intracranial nongerminomatous germ cell tumors producing alpha-fetoprotein. Neurosurgery 27: 454–460PubMedCrossRefGoogle Scholar
  22. 22.
    Itoyama Y, Kochi M, Kuratsu J, Kuratsu J, Uemura S, Ushio Y (1995) Treatment of intracranial nongerminomatous malignant germ cell tumors producing «-fetoprotein. Neurosurgery 36: 459–466PubMedCrossRefGoogle Scholar
  23. 23.
    Jenkin D, Berry M, Chan H, Greenberg M, Hendrick B, Hoffman H, Humphreys R, Sonley M, Weitzman S (1990) Pineal region germinomas in childhood. Treatment considerations. Int J Radiat Oncol Biol Phys 18: 541–545PubMedCrossRefGoogle Scholar
  24. 24.
    Jennings MT, Gelman R, Hochberg F (1985) Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg 63: 155–167PubMedCrossRefGoogle Scholar
  25. 25.
    Kida Y, Kobayashi T, Yoshida J, Kato K, Kageyama N (1986) Chemotherapy with cisplatin for AFP-secreting germ-cell tumors of the central nervous system. J Neurosurg 65: 470–475PubMedCrossRefGoogle Scholar
  26. 26.
    Kiltie AE, Gattamaneni HR (1995) Survival and quality of life of paediatric intracranial germ cell tumor patients treated at the Christie Hospital, 1972— 1993. Med Pediatr Oncol 25: 450–456PubMedCrossRefGoogle Scholar
  27. 27.
    Kirkove CS, Brown AP, Symon L (1991) Successful treatment of pineal endodermal sinus tumor. Case report. J Neurosurg 74: 832–836PubMedCrossRefGoogle Scholar
  28. 28.
    Kitamura K, Suzuki K, Shirato H, Kagei K, Aoyama H, Sawamura Y, Ikeda J, Miyasaka K (1997) Clinical trial of neoadjuvant chemotherapy combined with radiotherapy for primary intracranial germinoma. Int J Radiol Biol Phy 39: 278, (abstract)CrossRefGoogle Scholar
  29. 29.
    Kitamura T, Shirato H, Nishioka T, Kagei K, Yamaguchi M, Furuya T, Watanabe Y, Takekawa N, Miyasaka K (1998) A new mold material for customized patient positioning in radiotherapy. Radiat Oncol (in press)Google Scholar
  30. 30.
    Lee AC, Chan GC, Fung CF, Leung SY, Lau YL (1995) Paradoxical response of a pineal immature teratoma to combination chemotherapy. Med Pediatr Oncol 24: 53–57PubMedCrossRefGoogle Scholar
  31. 31.
    Linstadt D, Wara WM, Edwards MS, Hudgins RJ, Sheline GE (1988) Radiotherapy of primary intracranial germinomas: the case against routine craniospinal irradiation. Int. J Radiat Oncol Biol Phys 15: 291–297PubMedCrossRefGoogle Scholar
  32. 32.
    Loehrer PJ Sr, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH (1988) Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblsstine or etoposide. Ann Intern Med 109: 540–546PubMedGoogle Scholar
  33. 33.
    Loehrer PJ Sr, Williams SD, Einhorn LH (1989) Ifosfamide in testicular cancer: The Indian University experience. Semin Oncol 16: 96–101PubMedGoogle Scholar
  34. 34.
    Lötz JP, Andre T, Donsimoni R, Firmin C, Bouleuc C, Bonnak H, Marad Z, Esteso A, Gerota J, Izrael V (1995) High dose chemotherapy with ifosfamide, carboplatin and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adult. Cancer 75: 874–885PubMedCrossRefGoogle Scholar
  35. 35.
    Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N, Seto T (1997) Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 86: 446–455PubMedCrossRefGoogle Scholar
  36. 36.
    Motzer RJ, Cooper K, Geller NL, Geller NL, Bajorin DF, Dmitrovsky E, Herr H, Morse M, Fair W, Sogani P, Russo P (1990) The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Cancer 66: 2476–2481PubMedCrossRefGoogle Scholar
  37. 37.
    Olshan JS, Gubernick J, Packer RJ, D’Angio GJ, Goldwein JW, Willi SM, Moshang T Jr (1992) The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 70: 2013–2017PubMedCrossRefGoogle Scholar
  38. 38.
    Packer RJ, Sutton LN, Rorke LB, Rosenstock JG, Zimmerman RA, Littman P, Bilaniuk LT, Bruce DA, Schut L (1984) Intracranial embryonal cell carcinoma. Cancer 54: 520–524PubMedCrossRefGoogle Scholar
  39. 39.
    Sakai N, Yamada H, Andoh T, Hirata T, Shimizu K, Shinoda J (1988) Primary intracranial germ-cell tumors. A retrospective analysis with special reference to long-term results of treatment and the behavior of rare types of tumors. Acta Oncologica 27: 42–50CrossRefGoogle Scholar
  40. 40.
    Sakai N, Yamada H, Andoh T, Nishimura Y, Niikawa S (1993) Long-term survival in malignant intracranial germ-cell tumors: a report of two cases and a review of the literature. Childs Nerv Syst 9: 431–436PubMedCrossRefGoogle Scholar
  41. 41.
    Sano K (1995) So-called intracranial germ cell tumours: are they really of germ cell origin? Br J Neurosurg 9: 391–401PubMedCrossRefGoogle Scholar
  42. 42.
    Sawamura Y (1996) Current diagnosis and treatment of central nervous system germ cell tumours. Curr Opin Neuro 9: 419–423CrossRefGoogle Scholar
  43. 43.
    Sawamura Y, de Tribolet N, Ishii N, Abe H (1997) Surgical management of primary intracranial germinomas. Diagnostic surgery or radical resection? J Neurosurg 87: 262–266PubMedCrossRefGoogle Scholar
  44. 44.
    Sawamura Y, Shirato H, Ikeda J, Tada M, Ishii M, Kato T, Abe H, Fujieda K (1998a) Induction chemotherapy followed by reduced-volume irradiation for newly diagnosed CNS germinoma. J Neurosurg 88: 66–72PubMedCrossRefGoogle Scholar
  45. 45.
    Sawamura Y, Ikeda J, Shirato H, Tada M, Abe H (1998b) Germ cell tumours of the centralnervous system: Treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer 34: 104–110PubMedCrossRefGoogle Scholar
  46. 46.
    Schild SE, Haddock MG, Scheithaauer BW, Marks LB, Norman MG, Burger PC, Wong WW, Lyons MK, Schömberg PJ (1996a) Nongerminomatous germ cell tumors of the brain. Int J Radiat Oncol Biol Phys 36: 557– 563PubMedCrossRefGoogle Scholar
  47. 47.
    Schild SE, Scheithaauer BW, Haddock MG, Wong WW, Lyons MK, Marks LB, Norman MG, Burger PC (1996b) Histologically confirmed pineal tumors and other germ cell tumors of the brain. Cancer 78: 2564–2571PubMedCrossRefGoogle Scholar
  48. 48.
    Schmoll HJ (1989) The role of ifosfamide in testicular cancer. Semin Oncol 16: 82–93PubMedGoogle Scholar
  49. 49.
    Senan S, Rampling R, Kaye SB (1991) Malignant pineal teratomas: a report on three patients and the case for craniospinal irradiation following chemotherapy. Radiother Oncol 22: 209–21PubMedCrossRefGoogle Scholar
  50. 50.
    Shibamoto Y, Takahashi M, Abe M (1994) Reduction of the radiation dose for intracranial germinoma: a prospective study. Br J Cancer 70: 984–989PubMedCrossRefGoogle Scholar
  51. 51.
    Shirato H, Suzuki K, Nishioka T, Kamada T, Kagei K, Kitahara T, Morisawa H, Tsujii H (1994) Precise positioning of intracranial small tumors to the linear accelerator’s isocenter, using a stereotactic radiotherapy computed tomography system (SRT-CT). Radioth Oncol 32: 180–183CrossRefGoogle Scholar
  52. 52.
    Shirato H, Nishio M, Sawamura Y, Myohjin M, Kitahara T, Nishioka T, Mizutani Y, Abe H, Miyasaka K (1997) Analysis of long-term treatment of intracranial germinoma. Int J Radiat Oncol Biol Phys 37: 511–515PubMedCrossRefGoogle Scholar
  53. 53.
    Shokry A, Janzer RC, Von Hochstetter AR, Yasagil MG, Hedinger C (1985) Primary intracranial germ-cell tumors. A clinicopathological study of 14 cases. J Neurosurg 62: 826–830PubMedCrossRefGoogle Scholar
  54. 54.
    Sumida M, Uozumi T, Kiya K, Mukada K, Arita K, Kurisu K, Sugiyama K, Onda J (1995) MRI of intracranial germ cell tumours. Neuroradiology 37: 32– 37PubMedCrossRefGoogle Scholar
  55. 55.
    Wheeler BM, Loehrer PJ, Williams SD, Einhorn LH (1986) Ifosfamide in refractory male germ cell tumors. J Clin Oncol 4: 28–34PubMedGoogle Scholar
  56. 56.
    Wolden SL, Wara WM, Larson DA, Prados MD, Edwards MS, Sneed PK (1995) Radiation therapy for primary intracranial germ-cell tumors. Int J Radiat Oncol Biol Phys 32: 943–949PubMedCrossRefGoogle Scholar
  57. 57.
    Yoshida J, Sugita K, Kobayashi T, Takakura K, Shitara N, Matsutani M, Tanaka R, Nagai H, Yamada H, Yamashita J (1993) Prognosis of intracranial germ cell tumours: effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16). Acta Neurochir (Wien) 120: 111–117CrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1998

Authors and Affiliations

  • Y. Sawamura
    • 1
  • H. Shirato
    • 1
  1. 1.Departments of Neurosurgery and RadiologyHokkaido University School of MedicineSapporoJapan

Personalised recommendations